Clinical Trial Update: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC) [Phase 1]

View source ↗

Summary

The Phase 1 study of LCAR-G08 for advanced gastrointestinal tumors expressing guanylyl cyclase C has been terminated. No results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• LCAR-G08 (LCAR-G08)

Snippet

Sponsor: Peking University | Conditions: Advanced Gastrointestinal Tumors | Phase 1 | Status: TERMINATED